Ovine cortical osteoblasts outperform bone marrow cells in an ectopic bone assay

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 10, 2011, Pages 831-844

  Reichert, J C ^a,b   Quent, V M C ^a   Noth U ^b   Hutmacher, D W ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bone tissue engineering; Mesenchymal stem cells; Neovascularization bone morphogenetic protein; Precursor cells; Scaffolds

Indexed keywords

BONE; CELL ENGINEERING; OSTEOBLASTS; RECOMBINANT PROTEINS; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY; STEM CELLS; X RAY SPECTROSCOPY;

BONE MORPHOGENETIC PROTEIN-7; BONE MORPHOGENETIC PROTEINS; BONE TISSUE ENGINEERING; HUMAN BONE MORPHOGENETIC PROTEIN; MESENCHYMAL STEM CELL; NEO-VASCULARIZATION; NEOVASCULARIZATION BONE MORPHOGENETIC PROTEIN; PRECURSOR CELLS; TISSUE ENGINEERING APPLICATIONS; TRANSPLANTED CELLS;

CELL CULTURE;

BROXURIDINE; COLLAGEN TYPE 2; OSTEOCALCIN; RECOMBINANT OSTEOGENIC PROTEIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MATURATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SHEEP;

EID: 80054739904     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.392     Document Type: Article

References (47)

1. Angel NZ, Walsh N, Forwood MR, et al. 2000; Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15: 103-110.
2. Bastow ER, Byers S, Golub SB, et al. 2008; Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol Life Sci 65: 395-413.
3. Boskey AL, Gadaleta S, Gundberg C, et al. 1998; Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23: 187-196.
4. Chang SC, Tai CL, Chung HY, et al. 2009; Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation. Artif Organs 33: 301-308.
5. Chung ES, Saban DR, Chauhan SK, et al. 2009; Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci 50: 1613-1618.
6. Cowan CM, Aghaloo T, Chou YF, et al. 2007; MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 13: 501-512.
7. Deckers MM, van Bezooijen RL, van der Horst G, et al. 2002; Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143: 1545-1553.
8. Denker AE, Haas AR, Nicoll SB, et al. 1999; Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 64: 67-76.
9. Erlebacher A, and Derynck R. 1996; Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132: 195-210.
10. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. 2003; Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
11. Gittens SA, and Uludag H. 2001; Growth factor delivery for bone tissue engineering. J Drug Target 9: 407-429.
12. Granero-Molto F, Weis JA, Miga MI, et al. 2009; Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27: 1887-1898.
13. Haas AR, and Tuan RS. 1999; Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. Differentiation 64: 77-89.
14. Hauschka PV, and Wians FH, Jr. 1989; Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec 224: 180-188.
15. Hauschka PV, Lian JB, Cole DE, et al. 1989; Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047.
16. Hayman AR, Jones SJ, Boyde A, et al. 1996; Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122: 3151-3162.
17. Hentunen TA, Lakkakorpi PT, Tuukkanen J, et al. 1995; Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption. Biochem Biophys Res Commun 209: 433-443.
18. Kanczler JM, and Oreffo RO. 2008; Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114.
19. Kaneko H, Arakawa T, Mano H, et al. 2000; Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27: 479-486.
20. Lam CX, Hutmacher DW, Schantz JT, et al. 2009; Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A 90: 906-919.
21. Liu SB, Hu PZ, Hou Y, et al. 2009; Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro. Chin Med J (Engl) 122: 839-843.
22. Ljusberg J, Ek-Rylander B, and Andersson G. 1999; Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem J 343: 63-69.
23. Ljusberg J, Wang Y, Lang P, et al. 2005; Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem 280: 28370-28381.
24. Mandracchia VJ, Nelson SC, and Barp EA. 2001; Current concepts of bone healing. Clin Podiatr Med Surg 18: 55-77.
25. Minkin C. 1982; Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290.
26. Miura M, Miura Y, Padilla-Nash HM, et al. 2006; Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24: 1095-1103.
27. Noth U, Rackwitz L, Heymer A, et al. 2007; Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. J Biomed Mater Res A 83: 626-635.
28. Paul S, Lee JC, and Yeh LC. 2009; A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells. Growth Factors 27: 121-131.
29. Pluhar GE, Turner AS, Pierce AR, et al. 2006; A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model. J Bone Joint Surg Br 88: 960-966.
30. Reichert JC, Saifzadeh S, Wullschleger ME, et al. 2009; The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 30: 2149-2163.
31. Reichert JC, Woodruff MA, Friis T, et al. 2010; Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering. Applications in vitro and in vivo. J Tissue Eng Regen Med (in press).
32. Ripamonti U, Van Den Heever B, Sampath TK, et al. 1996; Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 13: 273-289, colour plates III-VIII.
33. Ristiniemi J, Flinkkila T, Hyvonen P, et al. 2007; RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J Bone Joint Surg Br 89: 265-272.
34. Sacchetti B, Funari A, Michienzi S, et al. 2007; Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
35. Shapiro F. 2008; Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15: 53-76.
36. Sheehan DC, Hrapchak BB. Theory and Practice of Histotechnology. Mosby: St. Louis, MO, 1980.
37. Sotiropoulou PA, Perez SA, Salagianni M, et al. 2006; Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24: 462-471.
38. ten Dijke P, Fu J, Schaap P, et al. 2003; Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85A(suppl 3): 34-38.
39. Tortelli F, and Cancedda R. 2009; Three-dimensional cultures of osteogenic and chondrogenic cells: a tissue engineering approach to mimic bone and cartilage in vitro. Eur Cell Mater 17: 1-14.
40. Tortelli F, Tasso R, Loiacono F, et al. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 31: 242-249.
41. Valdimarsdottir G, Goumans MJ, Rosendahl A, et al. 2002; Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106: 2263-2270.
42. Wagner W, Roderburg C, Wein F, et al. 2007; Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25: 2638-2647.
43. Wilson A, Oser GM, Jaworski M, et al. 2007; Dormant and self-renewing hematopoietic stem cells and their niches. Ann N Y Acad Sci 1106: 64-75.
44. Yeh LC, Adamo ML, Olson MS, et al. 1997; Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138: 4181-4190.
45. Yeh LC, Tsai AD, and Lee JC. 2002; Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 87: 292-304.
46. Young S, Patel ZS, Kretlow JD, et al. 2009; Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng A 15: 2347-2362.
47. Zhou Y, Chen F, Ho ST, et al. 2007; Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. Biomaterials 28: 814-824.